Man Group Adds $19M in The Cigna Group ($CI)
Key Points
- Man Group changed its The Cigna Group ($CI) stake by 29.35% last quarter, boosting to 306,301 shares worth $84.44 million.
- Wall Street's consensus rating on $CI is Buy and an average price target of $341.42.
- $CI last traded around $275.68.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Man Group increased its position in The Cigna Group ($CI) by 29.35% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 306,301 shares of The Cigna Group after buying 69,498 shares during the quarter. Man Group's holdings in The Cigna Group were worth $84.44 million as of its most recent filing.
The Cigna Group Stock Down 1.1%
Shares of The Cigna Group ($CI) traded around $275.68 on Saturday, down 1.1% for the day.
The Cigna Group Earnings
The Cigna Group Dividend
Analysts Set New Price Targets
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Get The Cigna Group alerts
New 13F filings, insider trades, and analyst moves on $CI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.